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1. Introduction
  Despite recent advancements in surgery and therapy, 
prostate cancer remains the most common cancer. Next only 
to lung cancer, it is the second leading cause of cancer-
related deaths in males[1]. Prostate cancer is generally 
detected in men over 50 years of age, usually at an advanced 
stage of the disease. Because of unsatisfactory outcomes 
associated with treating advanced cases of prostate cancer, 
there is a need to develop novel preventive approaches 
to control this disease. One such preventive approach is 
through chemoprevention by using naturally occurring 
dietary substances[2]. Epidemiological evidences strongly 
suggest that dietary habits such as the use of fruits and 
vegetables may have significant impact on the development 
of prostate cancer. Pigmented and tropical fruits and 
vegetables have been shown to contain many polyphenols, 
which contribute to their strong antioxidant and anti-
inflammatory properties[3]. Among the polyphenols, ellagic 
acid (C14H6O8) is gaining considerable popularity on the 
fast-expanding market of food supplements as they seem 
to possess potentially beneficial effects against various 
diseases[4]. 
  Ellagic acid is a polyphenolic compound present in fruits 
and berries such as pomegranates, strawberries, raspberries 
and blackberries. It has anticarcinogenic, antioxidant and 
Objective: To evaluate the effect of allagic acid treatment on the cell viability of human 
prostate cancer cells. Methods:  Ellagic acid (10-100 mol/L) treatment (48 h) of human prostate 
carcinoma PC3 cells was found to result in a dose-dependent inhibition of cell growth and 
apoptosis of PC3 cells as assessed by MTT assay, western blotting, flow cytometry and confocal 
microscopy. Results: We observed that ellagic acid treatment of PC3 cells resulted in a  dose 
dependent inhibition of cell growth/cell viability. This ellagic acid caused cell growth inhibition 
was found to be accompanied by induction of apoptosis, as assessed by the cleavage of poly 
(ADP-ribose) polymerase (PARP) and morphological changes. Further, induction of apoptosis 
accompanied a decrease in the levels of antiapoptotic protein Bcl-2 and increase in proapoptotic 
protein Bax, thus shifting the Bax: Bcl-2 ratio in favor of apoptosis. Ellagic acid treatment of 
PC3 cells was also found to result in significant activation of caspases, as shown by the dose 
dependent decrease in the protein expression of procaspase-3, -6, -8 and -9. This ellagic 
acid-mediated induction of apoptosis was significantly (80%-90%) inhibited by the caspase 
inhibitor N-benzyloxycarbonyl-Val-Ala-Asp (OMe)-fluoromethylketone (Z-VAD-FMK). Thus 
these data suggested an essential role of caspases in ellagic acid-mediated apoptosis of PC3 
cells. Conclusions: It is tempting to suggest that consumption of tropical pigmented fruits and 
vegetables could be an effective strategy to combat prostate cancer.
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antifibrosis properties[5-8]. The anticarcinogenic effect of 
ellagic acid was shown in several types of cancers including 
skin, esophageal, and colon cancers[8,9]. However, the 
effects of ellagic acid on prostate cancer have not been well 
studied. Furthermore, the mechanisms mediating anticancer 
effect of ellagic acid, in general, remain unknown. 
  Earlier we have reported the chemopreventive and 
chemotherapeutic effects of pomegranate juice against 
prostate cancer[10]. In this study, we show that ellagic acid 
might be the main polyphenol in the pomegranate that 
induces apoptosis and cell growth inhibition of highly 
aggressive human prostate cancer PC3 cells in an in vitro 
system. 
2. Materials and methods
2.1. Cell line and reagents
  PC-3 cells were obtained from American Type Culture 
Collection (Manassas, VA, USA) and were cultured in RPMI 
1640 medium supplemented with 5% heat-inactivated fetal 
bovine serum and 1% antibiotic penicillin and streptomycin. 
The cells were maintained under standard cell culture 
conditions at 37 曟 and 5% CO2 in a humid environment.
  Ellagic acid was purchased commercially from SIGMA 
chemicals (St. Louis, MO, USA). Antibodies to procaspases-3, 
-6, -8 and -9, were obtained from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA). Active caspases -3,-6,-8 and -9, 
PARP (85 kD) and Bcl-2 antibodies were procured from 
Cell Signaling Technology (Beverly, MA, USA). PARP (116 
kD) and Bax antibodies were purchased from Upstate 
Biotechnology (Lake Placid, NY, USA). The general caspase 
inhibitor Z-VAD-FMK was obtained from R & D Systems, Inc. 
(Minneapolis, MN, USA). 
  Secondary horseradish peroxidase-conjugated antibodies 
were purchased from Amersham (Arlington Heights, IL, 
USA). Anti-mouse or anti-rabbit secondary antibody 
horseradish peroxidase conjugate was obtained from 
Amersham Pharmacia Life Sciences. The Bio-Rad DC 
Protein Assay Kit was purchased from Bio-Rad. Novex 
precast Tris-Glycine gels were obtained from Invitrogen. 
The Annexin-V-FLUOS Staining Kit was purchased from 
Roche (Indianapolis, IN, USA). The APO-BRDU kit for 
quantification of apoptosis by flowcytometry was from 
Phoenix Flow Systems (San Diego, CA, USA).
2.2. Treatment of cells
  Cells were grown to 50%-70% confluence and then treated 
with freshly prepared ellagic acid (10-100 毺M/L) dissolved 
in DMSO (final concentration 0.1% v/v) for 48 hours for 
cell growth and apoptosis assays. For caspase-inhibition 
experiments, the cells were incubated with Z-VAD-FMK, a 
general caspase inhibitor, at the desired concentration, for 4 
hours before the addition of ellagic acid. 
2.3. Cell viability
  The effect of ellagic acid on the viability of cells was 
determined by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazoliumbromide assay. The cells were plated at 1伊 
10
4 cells per well in 200 毺L of complete culture medium 
containing 10-100 毺mol/L concentrations of ellagic acid 
in 96-well microtiter plates for 48 h. After incubation for 
specified times at 37 曟 in a humidified incubator, 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazoliumbromide 
(5 mg/mL in PBS) was added to each well and incubated for 
2 h, after which the plate was centrifuged at 1 800 伊 g for 5 
min at 4 曟. The absorbance was recorded on a microplate 
reader at the wavelength of 540 nm. The effect of ellagic acid 
on growth inhibition was assessed as percent cell viability 
where DMSO-treated cells were taken as 100% viable. DMSO 
at the concentrations used was without any effect on cell 
viability.
2.4. Detection of apoptosis by confocal microscopy
  The annexin-V-FLUOS staining kit was used for the 
detection of apoptosis following the vendor’s protocol. This 
kit uses a dual-staining protocol in which the apoptotic 
cells are stained with annexin-V (green fluorescence), and 
the necrotic cells are stained with propidium iodide (PI; red 
fluorescence). Cells were grown to about 70% confluence 
and then treated with ellagic acid (10-100 毺M/L) for 
48 hours. The fluorescence was detected by a Ziess 410 
confocal microscope. 
2.5. Quantification of apoptosis by flow cytometry
  For quantification of apoptosis, the cells were grown at a 
density of 1 x 106 cells in 100 mm culture dishes and were 
treated with varying doses of the ellagic acid and caspase 
inhibitor for 48 hours. The cells were trypsinized, washed 
with PBS, and were processed for labeling with fluorescein-
tagged deoxyuridine triphosphate nucleotide and propidium 
iodide by the use of an APO-DIRECT apoptosis kit. The 
labeled cells were analyzed by flow cytometry.
2.6. Western blot analysis
  The cells were harvested after treatment for 48 hours, 
homogenized in appropriate lysis buffer to prepare cell 
lysates[11]. Appropriate amount of protein (40 毺g) was 
resolved over 12% Tris-Glycine polyacrylamide gel and 
then transferred onto the nitrocellulose membrane. The blots 
were blocked using 5% non-fat dry milk and probed using 
appropriate primary antibody and the secondary horseradish 
peroxidase (HRP) conjugate. The proteins were detected by 
chemiluminescence.
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3. Results
3.1. Ellagic acid inhibits the growth of PC3 cells
  Our first aim was to evaluate the effect of ellagic acid 
treatment on the cell viability of human prostate cancer 
cells. Therefore, using human prostate carcinoma PC3 
cells, we first evaluated the effect of ellagic acid on the 
growth of these cells by 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl tetrazoliumbromide assay (MTT assay). Ellagic 
acid treatment to PC3 cells resulted in a significant dose-
dependent inhibition of cell growth (Figure 1). The IC50 value 
at 48 hours post treatment with ellagic acid for PC3 cells was 
80 毺mol/L.
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Figure 1. Effect of ellagic acid on cell viability and apoptosis of PC3 
cells. 
PC3 cells were treated with vehicle alone (0.1% DMSO) and specified 
concentrations of ellagic acid in 0.1% DMSO for 48 h, and cell 
viability was determined by MTT assay as detailed in Materials and 
Methods. The values are represented as the percent viable cells, with 
vehicle-treated cells regarded as 100% viable. Data shown are mean 
依 SD of three separate experiments in which each treatment was 
repeated in 10 wells.
3.2. Ellagic acid induces apoptosis in PC3 cells as assessed 
by fluorescence microscopy
  To access whether ellagic acid-mediated decrease in 
cell growth is due to induction of apoptosis, we conducted 
Annexin V and propidium iodide stainings in ellagic acid-
treated cells. We used this method because it identifies 
the apoptotic (green fluorescence) as well as necrotic (red 
fluorescence) cells. Data showed a significant induction 
of apoptosis by ellagic acid which was evident from the 
significant enhancement in Annexin V staining (Figure 2).
3.3. Ellagic acid brings on PARP cleavage
  During the induction of apoptosis, DNA fragmentation 
leads to activation of Poly (ADP-ribose) polymerase (PARP); 
therefore, cleavage of PARP protein is considered as an 
important biomarker of apoptosis. Immunoblot analysis 
showed a significant dose-dependent increase in cleaved 
PARP in cells treated with ellagic acid (Figure 3).
                Control                                          Ellagic acid (40 毺mol/L)     
Ellagic acid (100 毺mol/L)
Ellagic acid (60 毺mol/L)                        Ellagic acid (80 毺mol/L) 
Figure 2. Representative micrographs of PC3 cells undergoing 
apoptosis induced by treatment with specified concentrations of 
ellagic acid for 48 h as assessed by fluorescence microscopy. 
Green fluorescence of Annexin V staining represents the cells 
undergoing apoptosis and red fluorescence of propidium iodide shows 
the cells undergoing either necrosis or late apoptosis as detected with 
a Zeiss Axiovert 100 microscope.
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Figure 3. Effect on cleavage of PARP. 
The cells were treated with vehicle only or specified concentrations 
of ellagic acid for 48 h and harvested, and cell lysates were prepared. 
The data are representative of three independent experiments with 
similar results. The values above the blots represent the change in the 
protein expression of the bands normalized to 毬-actin where vehicle-
treated cells are represented as 1.0.
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3.4. Ellagic acid alters Bax and Bcl-2 protein expression in 
PC3 cells
  Bcl2 forms a heterodimeric complex with the apoptotic Bax 
protein, thereby neutralizing its apoptotic effects. Therefore, 
the ratio of Bax/Bcl2 is often considered as a decisive 
factor in determining whether cells will undergo death or 
survive. We observed that ellagic acid treatment of cells 
resulted in a decrease in Bcl2 expression with a concomitant 
increase in the protein level of Bax (Figure 4). This resulted 
in a substantial increase in Bax/Bcl2 ratio, which favors 
apoptosis. Taken together, these findings suggest that 
cleavage in PARP protein, up-regulation of Bax, and down-
regulation of Bcl2 may collectively form a molecular basis 
for the apoptotic action of ellagic acid.
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Figure 4: Effect of ellagic acid treatment of PC3 cells on protein 
expression of Bax and Bcl2 and the Bax/Bcl2 ratio. 
The cells were treated with vehicle only or specified concentrations 
of ellagic acid for 48 h and harvested, and cell lysates were prepared. 
The data are representative of three independent experiments with 
similar results. The values above the blots represent the change in the 
protein expression of the bands normalized to 毬-actin where vehicle-
treated cells are represented as 1.0.
3.5. Ellagic acid stimulates apoptosis through activation of 
caspases in PC3
  In most cancer cells, caspases are present in the pro-
forms (inactive) and require site-specific cleavage of the 
protein to become active and participate in the process 
of apoptosis. To test whether caspases are involved in 
apoptosis induction by ellagic acid, we first evaluated 
the protein levels of procaspases and active caspases 
in ellagic acid-treated cells. Data presented showed 
a significant and progressive increase in the levels of 
initiator caspases (active caspase-8 and caspase-9) as 
well as effector caspases (active caspase-3 and caspase-6) 
proteins in ellagic acid-treated cells (Figure 5 and 6). 
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Figure 5. Effect of ellagic acid on initiator caspases in PC3 cells. 
PC3 cells were treated with vehicle alone (0.1% DMSO) or specified 
concentrations of ellagic acid in 0.1% DMSO for 48 h as detailed in 
Materials and methods.  
Protein levels of procaspase-8, procaspase-9, active caspase-8, and 
caspase-9 in PC3 cells were determined by immunoblot analysis. The data are 
representative of three independent experiments with similar results. The values 
above the blots represent the change in the protein expression of the bands 
normalized to 毬-actin where vehicle-treated cells are represented as 1.0.
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Figure 6. Effect of ellagic acid on effector caspases in PC3 cells. 
PC3 cells were treated with vehicle alone (0.1% DMSO) or specified 
concentrations of ellagic acid in 0.1% DMSO for 48 h as detailed in 
Materials and Methods.  Protein levels of procaspase-3, procaspase-6, 
active caspase-3, and caspase-6 in PC3 cells were determined by 
immunoblot analysis. The data are representative of three independent 
experiments with similar results. The values above the blots represent 
the change in the protein expression of the bands normalized to 毬
-actin where vehicle-treated cells are represented as 1.0.
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    To test whether ellagic acid induces apoptosis via 
activation of caspases, we used a general caspases inhibitor, 
Z-VAD-FMK. Ellagic acid (80 μmol/L)-treated cells 
exhibited 29.6% terminal deoxyribonucleotidyl transferase-
mediated dUTP nick end labeling-positive cells, which was 
significantly reduced to 9.45% with the treatment of cells 
with Z-VAD-FMK (Figure 7). 
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Figure 7. Inhibition of caspase activity as assessed by flow cytometry. 
PC3 cells were treated with 10 毺mol/L concentration of the general 
caspase inhibitor Z-VAD-FMK for 4 h, followed by the treatment 
with the indicated dose of ellagic acid for 48 h. Cells showing dUTP 
fluorescence above that of control population, as indicated by the line 
in each histogram, are considered as apoptotic cells.
  Immunoblot analysis also showed that ellagic acid-induced 
activation of caspases-3, 6, 8 and-9 was significantly 
reduced after caspase inhibitor treatment (Figure 8). These 
results suggest that induction of caspases may be a possible 
mechanism by which ellagic acid induces apoptosis in PC3 
cells.
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Figure 8. Inhibition of caspase activity as assessed by western blot 
analysis. 
PC3 cells were treated with 10 毺mol/L concentration of the general 
caspase inhibitor Z-VAD-FMK for 4 h, followed by the treatment 
with the indicated doses of ellagic acid for 48 h. The data are 
representative of three independent experiments with similar results. 
The values above the blots represent the change in the protein 
expression of the bands normalized to 毬-actin where vehicle-treated 
cells are represented as 1.0.
4. Discussion
  Recently, chemoprevention and other intervention 
approaches using naturally occurring agents have come 
out as a promising choice that could prevent or slow the 
tumor growth thus improve the quality of life of prostate 
cancer patients. In this regard, several fruit- and vegetable-
derived chemopreventive agents have been reported 
that induce apoptosis in cancer cells in both in vitro and 
in vivo systems[12,13]. We have previously reported that 
pomegranate juice brings on apoptosis in prostate cancer 
cells and inhibits tumor growth in athymic nude mice[10]. 
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In the present study we showed that ellagic acid might be 
the main potential polyphenol in the pomegranate. Here 
we observed the antiproliferative effect of ellagic acid on 
PC3 cells. We found that the primary mode of ellagic acid-
mediated inhibition of tumor growth is through the induction 
of apoptosis. 
  Because caspases have been shown to be involved 
in apoptosis[14,15] via activation of downstream effector 
molecules such as PARP[16,17], we found that the induction 
of apoptosis by ellagic acid is governed primarily by the 
activation of caspases because pretreatment with Z-VAD-
FMK, a caspase inhibitor, significantly prevented ellagic 
acid-mediated apoptosis.
  Members of the Bcl-2 family of proteins are critical 
regulators of the apoptotic pathway. Bcl-2 is an upstream 
effector molecule in the apoptotic pathway and is identified 
as a potent suppressor of apoptosis[18]. Bcl-2 is found at 
inappropriately high levels in more than half of all human 
tumors[19,20]. Bcl-2 has been shown to form a heterodimer 
complex with the proapoptotic member Bax, thereby 
neutralizing its proapoptotic effects. Therefore, the ratio 
of Bax/Bcl-2 is a decisive factor and plays an important 
role in determining whether cells will undergo death or 
survival. In our study, ellagic acid treatment of PC3 cells 
for 48 h was found to result in a decrease in Bcl-2 protein 
expression with an increase in the protein expression of Bax 
Importantly, in ellagic acid-treated cells, the ratio of Bax 
to Bcl-2 was found to be altered in favor of apoptosis. Our 
results thus suggest that up-regulation of Bax and down-
modulation of Bcl-2 may be another molecular mechanism 
through which ellagic acid induces apoptosis.
  Thus this present study is showing the effect of ellagic 
acid in inhibiting human prostate cancer cell growth in in 
vitro model via activation of caspase pathway. There is an 
increasing interest in the use of natural products for cancer 
treatments. Based on the present findings, it is tempting to 
suggest that ellagic acid could be developed as a potential 
anticancer agent against human prostate cancer cells.
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